Centessa Pharmaceuticals

+$0.08 (+1.94%) As of 2:05 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTA and other ETFs, options, and stocks.

About CNTA

Centessa Pharmaceuticals Plc is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. Its portfolio consists of preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases.

CEO
Saurabh Saha
Employees
199
Headquarters
Altrincham, Cambridgeshire
Founded
2013

CNTA Key Statistics

Market cap
397.71M
Price-Earnings ratio
—
Dividend yield
—
Average volume
244.78K
High today
$4.20
Low today
$4.08
Open price
$4.10
Volume
17.10K
52 Week high
$26.90
52 Week low
$4.05

CNTA Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.70 per share
Actual
-$0.60 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure